2Chereau E, Lavoue V, Ballester M, et al. External validation of a laparo- scopic-based score to evaluate resectability for patients with advanced o- varian cancer undergoing interval debulking surgery[ J]. Anticancer Res, 2011 ,31 (12) :4469-74.
3Bristow RE, Tomaruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era : a meta-analysis[J]. J Clin Onco1,2002 ,20 (5) : 1248-59.
4Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in ad- vanced epithelial ovarian carcinoma [J]. Gynecol Oncol, 2001 , 82 ( 3 ) : 532-7.
5Hou JY, Kelly MG, Yu H, et al. Neoadjuvant chemotherapy lessens surgi- cal morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease [ J ]. Gynecol 0ncol,2007 , 105 ( 1 ) :211-7.
7Shirabe K, Kajiyama K, Harimoto N,et al. Early outcome following hepatic resection in patients older than 80 years of age[ J]. World J Surg,2009, 33(9) :1927-32.
8Peled E, Keren Y, Halachmi S ,et aI. Patients aged 80 and older undergo- ing orthopedic or urologic surgery:a prospective study focusing on pefiop- erative morbidity and mortality[ J]. Gerontology,2009 ,55 (5) :517-22.
3Schwartz PE.Neoadjuvent chemotherapy for the management of ovarian cancer [J]. Best Pract Res Clin Obstet Gynaecol,2002,16(4): 585-596.
4Chambers JT,Chambers SK,Voynick IM,et al. Neoadjuvant chemotherapy in stage X ovarian carcinoma [J]. Gynecol Oncol, 1990,37(3) :327-331.
5Vergote I, De Wever I,Tjalma W, et al.Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma:a retrospective analysis of 285 patients [ J ]. Gynecol Oncol, 1998,71 (3) : 431-436.
6Hegazy MA, Hegazi RA, Elshafei MA, et al.Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma [J]. World J Surg Oncol, 2005,3 : 57.
7Bristow RE,Tomacruz RS,Armstrong DK,et al.Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era : a meta-analysis [ J ]. J Clin Oneol, 2002,20 (5) : 1248-1259.
8Chi DS, Liao JB, Leon LF, et al.Identification of prognostic factors in advanced epithelial ovarian carcinoma [J ]. Gynecol Oncol, 2001,82 (3) : 532-537.
9Kuhn W,Rutke S,Spathe K,et al.Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma [J]. Cancer, 2001,92(10) :2585-2589.
10Inciura A, Simavicius A, Juozaityte E, et al.Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer:a retrospective study of 574 patients [J]. BMC Cancer,2006,6:153.
